Unknown molecular target in sensitive α-proteobacteria

The Unknown molecular target in sensitive α-proteobacteria refers to an unidentified molecular entity or pathway within the α-proteobacteria class that is susceptible to inhibition by certain antimicrobial compounds. This designation is frequently employed in pharmacological databases, such as ChEMBL, to categorize bioactivity data from phenotypic screens where the specific mechanism of action has not been definitively elucidated (Mendez et al., 2019). α-proteobacteria encompass a diverse group of bacteria, including significant human and animal pathogens like Rickettsia, Brucella, and the endosymbiont Wolbachia. A critical pharmacological consideration for drugs targeting this group is the evolutionary relationship between α-proteobacteria and eukaryotic mitochondria, which can lead to off-target mitochondrial toxicity in host cells (Gray et al., 1999). Consequently, compounds that show activity against these unidentified targets must be carefully screened for safety to avoid interfering with host mitochondrial function. Identifying the precise molecular targets, such as specific enzymes or ribosomal subunits, remains a key objective for the rational design of narrow-spectrum antibiotics. Currently, drugs like tetracyclines are often used as reference agents for their broad activity against sensitive members of this bacterial class.

Other names

Unidentified target in alpha-proteobacteriaPhenotypic target in alpha-proteobacteriaUnknown molecular target in sensitive α-proteobacteria (ChEMBL2367113)

Inhibition of bacterial growth through an unidentified molecular mechanism, potentially involving the disruption of protein synthesis, cell wall integrity, or essential metabolic pathways.